leisure time -WSS

leisure time

author：Wikipedia 2025-09-11 10:29:04 - browse：64

Perrigo Opill press photo – pharma coverage from STAT — Opill, the first over-the-counter birth control pill, is on its way to U.S. stores. Perrigo via AP

WASHINGTON — The first over-the-counter birth control pill will be available in U.S. stores later this month, allowing American women and teens to purchase contraceptive medication as easily as they buy aspirin.

Manufacturer Perrigo said Monday it has begun shipping the medication, Opill, to major retailers and pharmacies. A one-month supply will cost about $20 and a three-month supply will cost around $50, according to the company’s suggested retail price. It will also be sold online.

The launch has been closely watched since last July, when the Food and Drug Administration said the once-a-day Opill could be sold without a prescription. Ireland-based Perrigo noted there will be no age restrictions on sales, similar to other over-the-counter medications.

Opill is an older class of contraceptive, sometimes called minipills, that contain a single synthetic hormone, progestin, and generally carry fewer side effects than more popular combination estrogen and progestin pills.

Newsletters

Sign up for Morning Rounds

Understand how science, health policy, and medicine shape the world every day

Please enter a valid email address. Privacy Policy

The launch gives U.S. women another birth control option amid the legal and political battles over reproductive health, including the reversal of Roe v. Wade, which has upended abortion access across the U.S. Opill’s approval is unrelated to the ongoing court battles over the abortion pill mifepristone. And anti-abortion groups have generally emphasized that they do not oppose contraceptives to prevent pregnancies.

Birth control pills are available without a prescription across much of South America, Asia, and Africa.

The drug’s approval came despite some concerns by FDA scientists about the company’s results, including whether women with certain medical conditions would understand that they shouldn’t take the drug.

Dr. Verda Hicks, president of the American College of Obstetricians and Gynecologists, in a statement, said studies have shown that patients, including adolescents, can effectively screen themselves to use the pills.

— Matthew Perrone

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： What we need to know about Arena Bioworks

WSS

Why you get paid to donate plasma but not blood

Commercial surrogacy can be ethical, despite pope’s claims

Idaho college killings: Prosecutors dispute DNA could have been planted at murder scene

Ford plant in Missouri shuts down over 'possible threat,' sheriff's office says

Twill hunts for pharma partner to market its depression app

Vertex non

focus

leisure time

Sign up for Morning Rounds

leisure time

At least 13 dead in Texas as scorching temps continue

US soldier in North Korean custody after crossing DMZ line

Jerome Adams on the need for new antivirals for Covid

Cybersecurity threat forces Lurie Children's to take systems offline

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Juul spent big to court Black leaders to promote its e

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Robert Kennedy Jr.'s presidential campaign attracts GOP

As demand for Covid shots wanes, Moderna seeks its next success

Cognito secures funding to test medical device for Alzheimer's

knowledge

Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

Asa Hutchinson previews new plan to reform federal law enforcement if elected in 2024

Study: Hearing aids may slow cognitive decline in those at risk

Flagship, Pfizer team up in deal worth up to $7 billion

UK homeowners get some respite as inflation falls by more than anticipated to a 15

Woodcock on FDA’s accelerated approval and her next chapter

focus

hotspot

knowledge

Wikipedia